News
March 10, 2015
At the 2015 Conference on Retroviruses and Opportunistic Infections (CROI Conference) in Seattle, Washington, Dr. Steven Grinspoon, Co-PI of the REPRIEVE trial, is interviewed on the topic of his plenary presentation: “Cardiovascular Disease in HIV Patients: An Emerging Paradigm and Call to Action”.
October 27, 2014
BOSTON – A nationwide study based at Massachusetts General Hospital (MGH) will investigate, for the first time, whether treatment with a statin drug can reduce the elevated risk of cardiovascular disease in individuals infected with the human immunodeficiency virus (HIV).
October 22, 2014
He was 29 when he began antiretroviral therapy.He was 43 when he had a heart attack.“I felt fluttery,” he said. “Weird and fluttery. It went away. I ignored it. A week later, it came back, and this time I felt something in my arm too. I was too stupid to call an ambulance. I got in a cab and went to the hospital.”